GlassScriptPhysician profile
Jonathan A Krathen
NPI 1598023996
$8,728.52
in general payments reported to CMS, 2019-2025
24 companies · $2,374 in 2025
The $2,374 reported for 2025 was more than what 86% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,771 · 2020: $117 · 2021: $732 · 2022: $827 · 2023: $1,113 · 2024: $1,794 · 2025: $2,374.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,923 · Travel and Lodging: $2,358.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,922.85 |
| Travel and Lodging | $2,357.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,614.46 | 2019-2025 | Aveir, Jot Dx, Confirm Rx |
| Medical Device Business Services, INC. | $870.50 | 2019 | |
| Biotronik INC. | $771.47 | 2019-2025 | Biomonitor, Amvia Edge |
| Boston Scientific Corporation | $755.12 | 2021-2024 | S-Icd System Magnet, Lux-Dx Insertable Cardiac Monitor, Bodyguardian |
| Biosense Webster, INC. | $378.49 | 2021-2023 | Nuvision Ice Catheter |
| Philips North America LLC | $228.21 | 2022-2025 | (5050) Extended Holter, Extended Holter |
| Medtronic Vascular, INC. | $224.99 | 2019 | |
| Saranas, INC. | $142.58 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $108.59 | 2019-2024 | Wainua |
| Irhythm Technologies, INC. | $94.12 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Medtronic, INC. | $85.86 | 2023-2025 | Pulseselect, Affera Mapping System, Micra |
| Pfizer INC. | $61.56 | 2019-2020 | |
| Baxter Healthcare | $50.54 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Novo Nordisk INC | $44.26 | 2024 | Rybelsus, Ozempic, Wegovy |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $42.90 | 2022-2023 | Lifevest |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stereotaxis INC | $42.43 | 2021 | |
| Janssen Pharmaceuticals, INC | $42.12 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $38.84 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $37.90 | 2023-2024 | |
| Altathera Pharmaceuticals LLC | $34.54 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $15.51 | 2023 | Inpefa |
| Merck Sharp & Dohme LLC | $15.27 | 2023 | Verquvo |
| Kestra Medical Technology Services, INC. | $14.18 | 2022 | |
| Chiesi USA, INC. | $14.08 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Krathen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.